Bioequivalence and Bioavailability Forum 03:17 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

95% Upper bound calculation [RSABE / ABEL]

posted by GM - India, 2018-03-07 06:25  - Posting: # 18502
Views: 1,009

Hello All :waving:,

Hope all are doing well...!!!

Do anybody suggest manual calculation of 95% upper bound in RSABE approach....

Actually I am trying to do this for IVPT study analysis using guidance Acyclovir 5% cream. But here the reference treatment was replicated more than 2 times.

Is it possible to follow the RSABE approach as per the Progesterone Guidance..?

Kindly suggest me something relavent to this.

Thankyou in Advance :-).

Regards,
GM

Best Regards,
GM

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,698 posts in 3,983 threads, 1,235 registered users;
online 13 (0 registered, 13 guests [including 10 identified bots]).

When puzzled, it never hurts to read the primary documents –
a rather simple and self-evident principle that has, nonetheless,
completely disappeared from large sectors
of the American experience.    Stephen Jay Gould

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed